Gary Michael Felker, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 7th Fl 2400 Pratt St, Durham, NC 27705
Phone (919) 668-8919
Email address michael.felker@duke.edu

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1999 - 2002
  • Fellow in Cardiology, Medicine, Johns Hopkins University, 1998 - 1999
  • Assistant Chief of Service, Medicine, Johns Hopkins University, 1997 - 1998
  • Faculty, Medicine, Union Memorial Hospital, 1996 - 1997
  • Medical Resident, Medicine, Johns Hopkins University, 1993 - 1996
  • M.D., Duke University, 1993

Publications

Ibrahim, Nasrien E., John C. Burnett, Javed Butler, Alexander Camacho, G Michael Felker, Mona Fiuzat, Christopher O’Connor, et al. “Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper.” Jacc Heart Fail 8, no. 5 (May 2020): 347–58. https://doi.org/10.1016/j.jchf.2019.12.010.

PMID
32171762
Full Text

Fiuzat, Mona, Justin Ezekowitz, Wendimagegn Alemayehu, Cynthia M. Westerhout, Marco Sbolli, Dario Cani, David J. Whellan, et al. “Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.” Jama Cardiol, April 22, 2020. https://doi.org/10.1001/jamacardio.2020.0640.

PMID
32319999
Full Text

Fiuzat, Mona, Naomi Lowy, Norman Stockbridge, Marco Sbolli, Federica Latta, JoAnn Lindenfeld, Eldrin F. Lewis, et al. “Endpoints in Heart Failure Drug Development: History and Future.” Jacc Heart Fail, April 6, 2020. https://doi.org/10.1016/j.jchf.2019.12.011.

PMID
32278679
Full Text

Teerlink, John R., Rafael Diaz, G Michael Felker, John J. V. McMurray, Marco Metra, Scott D. Solomon, Jason C. Legg, et al. “Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF.” Jacc Heart Fail 8, no. 4 (April 2020): 329–40. https://doi.org/10.1016/j.jchf.2019.12.001.

PMID
32035892
Full Text

Janwanishstaporn, Satit, Siting Feng, John Teerlink, Marco Metra, Gad Cotter, Beth A. Davison, G Michael Felker, et al. “Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial.” Eur J Heart Fail 22, no. 4 (April 2020): 726–38. https://doi.org/10.1002/ejhf.1772.

PMID
32141161
Full Text

Felker, G Michael, David H. Ellison, Wilfried Mullens, Zachary L. Cox, and Jeffrey M. Testani. “Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.” J Am Coll Cardiol 75, no. 10 (March 17, 2020): 1178–95. https://doi.org/10.1016/j.jacc.2019.12.059.

PMID
32164892
Full Text

Reddy, Yogesh N. V., Masaru Obokata, Jeffrey M. Testani, G Michael Felker, WH Wilson Tang, Omar F. Abou-Ezzeddine, Jie-Lena Sun, et al. “Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction.” J Card Fail 26, no. 2 (February 2020): 101–7. https://doi.org/10.1016/j.cardfail.2019.09.015.

PMID
31618698
Full Text

Sharma, Abhinav, Jingjing Wu, Justin A. Ezekowitz, Gary Michael Felker, Jacob A. Udell, Paul A. Heidenreich, Gregg C. Fonarow, Kenneth W. Mahaffey, Adrian F. Hernandez, and Adam D. DeVore. “Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.” Esc Heart Fail 7, no. 1 (February 2020): 274–78. https://doi.org/10.1002/ehf2.12528.

PMID
31747132
Full Text

Pages